Chargement en cours...
Management of patients with advanced non-small cell lung cancer: role of gefitinib
Gefitinib is the first epidermal growth factor receptor tyrosine-kinase inhibitor approved for the treatment of advanced non-small cell lung cancer (NSCLC). Its failure to improve survival in a placebo-control study, however, led to its withdrawal in the United States though it is available in many...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2880342/ https://ncbi.nlm.nih.gov/pubmed/20531966 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|